International Clinical Trial: Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130786) titled 'Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases' on Aug. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Ayal A. Aizer, MD

Condition: Seizures Primary Motor Cortex Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Brain Metastases, Adult Brain Metastases From Extra-cranial Solid Tumors

Intervention: Drug: Levetiracetam (Keppra)

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enr...